NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,264 | -84.3% | 57,528 | -84.8% | 0.00% | -100.0% |
| Q2 2023 | $217,655 | +77.0% | 378,398 | +595.3% | 0.00% | 0.0% |
| Q4 2022 | $122,989 | -27.2% | 54,420 | +22.4% | 0.00% | 0.0% |
| Q2 2022 | $169,000 | -72.2% | 44,471 | +57.9% | 0.00% | -94.7% |
| Q4 2019 | $608,000 | +85.4% | 28,157 | +205.9% | 0.02% | -75.6% |
| Q2 2019 | $328,000 | +60.0% | 9,205 | +47.6% | 0.08% | -11.4% |
| Q4 2018 | $205,000 | -50.0% | 6,237 | -7.3% | 0.09% | +60.0% |
| Q3 2018 | $410,000 | – | 6,726 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |